Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 1034
Function: getPubMedXML
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3152
Function: GetPubMedArticleOutput_2016
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
Two different experimental models are presented for the induction of immunosuppression and immunological tolerance in mice with antineoplastic drugs: a) an unspecific T cell activation with a phytomitogen (phytohemagglutinin), or b) a partial synchronization of antigen-induced proliferation by mitotic blockade with vincristinsulfate prepare lymphoid tissue for an increased sensitivity to cyclophosphamide. With the first model a complete (antigen-nonspecific) inhibition of antibody production--mediated by an inactivation of T cells which act synergistically with antibody-forming cell precursors during the induction of the humoral immune response ("helper cells") -- has been demonstrated. The second model was shown to be suitable for the induction of immunotolerance, indicating a rather selective suppression of a clone of antigen-specific cells.
Download full-text PDF |
Source |
---|
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!